1. Home
  2. TIL vs MFIN Comparison

TIL vs MFIN Comparison

Compare TIL & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • MFIN
  • Stock Information
  • Founded
  • TIL 2018
  • MFIN 1995
  • Country
  • TIL United States
  • MFIN United States
  • Employees
  • TIL N/A
  • MFIN N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • MFIN Finance: Consumer Services
  • Sector
  • TIL Health Care
  • MFIN Finance
  • Exchange
  • TIL Nasdaq
  • MFIN Nasdaq
  • Market Cap
  • TIL 170.7M
  • MFIN 190.0M
  • IPO Year
  • TIL 2021
  • MFIN 1996
  • Fundamental
  • Price
  • TIL $21.17
  • MFIN $9.95
  • Analyst Decision
  • TIL Buy
  • MFIN
  • Analyst Count
  • TIL 4
  • MFIN 0
  • Target Price
  • TIL $100.33
  • MFIN N/A
  • AVG Volume (30 Days)
  • TIL 107.5K
  • MFIN 73.6K
  • Earning Date
  • TIL 11-13-2024
  • MFIN 10-29-2024
  • Dividend Yield
  • TIL N/A
  • MFIN 4.44%
  • EPS Growth
  • TIL N/A
  • MFIN N/A
  • EPS
  • TIL N/A
  • MFIN 1.69
  • Revenue
  • TIL N/A
  • MFIN $293,257,000.00
  • Revenue This Year
  • TIL N/A
  • MFIN N/A
  • Revenue Next Year
  • TIL $2.65
  • MFIN $10.95
  • P/E Ratio
  • TIL N/A
  • MFIN $5.86
  • Revenue Growth
  • TIL N/A
  • MFIN 18.48
  • 52 Week Low
  • TIL $6.72
  • MFIN $6.48
  • 52 Week High
  • TIL $92.00
  • MFIN $10.50
  • Technical
  • Relative Strength Index (RSI)
  • TIL 36.47
  • MFIN 54.90
  • Support Level
  • TIL $20.57
  • MFIN $9.83
  • Resistance Level
  • TIL $22.69
  • MFIN $10.50
  • Average True Range (ATR)
  • TIL 2.72
  • MFIN 0.29
  • MACD
  • TIL -0.23
  • MFIN 0.01
  • Stochastic Oscillator
  • TIL 2.98
  • MFIN 48.33

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About MFIN Medallion Financial Corp.

Medallion Financial Corp is a finance company that originates and services loans in various industries. Its operating segments include recreation, home improvement, commercial lending, medallion lending and Corporate and Other Investments. The company generates maximum revenue from the Recreation segment.

Share on Social Networks: